- $221.21m
- $154.31m
- $408.52m
Nevro Corp expected to post a loss of $1.05 a share - Earnings Preview
Nevro Corp reports results for the quarter ended in December - Earnings Summary
U.S. RESEARCH ROUNDUP-Analog Devices, Mosaic, Workday
Brief: Nevro Corp Says On February 20 Entered Into A Cooperation Agreement With Certain Affiliates Of Engaged Capital
Brief: Nevro Enters Into Cooperation Agreement With Engaged Capital
Brief: Nevro Q4 Revenue USD 116.176 Million Vs. IBES Estimate USD 112.5 Million
Nevro Corp expected to post a loss of 49 cents a share - Earnings Preview
Brief: Nevro Announces Consensus Statement Supporting High-Frequency Spinal Cord Stimulation Therapy For Refractory Painful Diabetic Neuropathy
U.S. RESEARCH ROUNDUP-American Water Works Company, Home Depot, Lowe's
Brief: Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
Nevro Corp rises on job cuts, better-than-expected prelim Q4 revenue
Brief: Engaged Capital Reports 6.0% Stake In Nevro Corp As Of Dec 4 - SEC Filing
Nevro Corp reports results for the quarter ended in September - Earnings Summary
Brief: Nevro Q3 Revenue USD 103.862 Million Vs. IBES Estimate USD 96.5 Million
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp reports results for the quarter ended in June - Earnings Summary
Brief: Nevro Q2 Revenue USD 108.809 Million Vs. IBES Estimate USD 106.9 Million
Nevro Corp expected to post a loss of 69 cents a share - Earnings Preview
Nevro down on trimming Q2 revenue forecast